Raffles Medical Group Ltd
General ticker "RAFLF" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.3B (TTM average)
Raffles Medical Group Ltd follows the US Stock Market performance with the rate: 44.5%.
Estimated limits based on current volatility of 0.0%: low 0.72$, high 0.72$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-05-15, amount 0.02$ (Y5.56%)
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.61$, 1.13$]
- 2024-12-30 to 2025-12-30 estimated range: [0.62$, 1.15$]
Financial Metrics affecting the RAFLF estimates:
- Positive: with PPE of 16.7 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 16.35
- Negative: Industry operating cash flow per share per price (median), % of 0.99 <= 5.52
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.63
- Negative: 0.01 < Interest expense per share per price, % of 0.31
- Positive: Shareholder equity ratio, % of 67.25 > 63.39
- Positive: Inventory ratio change, % of 0.16 <= 0.84
- Negative: Operating cash flow per share per price, % of 9.56 <= 13.24
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term RAFLF quotes
Long-term RAFLF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SGD822.92MM | SGD708.03MM | SGD751.56MM |
| Operating Expenses | SGD627.07MM | SGD592.28MM | SGD669.07MM |
| Operating Income | SGD195.85MM | SGD115.75MM | SGD82.49MM |
| Non-Operating Income | SGD-4.14MM | SGD3.68MM | SGD4.47MM |
| Interest Expense | SGD6.88MM | SGD6.08MM | SGD5.78MM |
| Income(Loss) | SGD191.70MM | SGD119.44MM | SGD86.96MM |
| Taxes | SGD48.00MM | SGD28.35MM | SGD24.68MM |
| Profit(Loss)* | SGD143.21MM | SGD90.15MM | SGD62.24MM |
| Stockholders Equity | SGD1,015.05MM | SGD1,027.74MM | SGD1,049.77MM |
| Inventory | SGD13.10MM | SGD12.46MM | SGD10.76MM |
| Assets | SGD1,497.70MM | SGD1,528.23MM | SGD1,530.79MM |
| Operating Cash Flow | SGD196.22MM | SGD189.31MM | SGD86.25MM |
| Capital expenditure | SGD25.30MM | SGD20.52MM | SGD20.91MM |
| Investing Cash Flow | SGD-22.83MM | SGD-12.41MM | SGD-9.87MM |
| Financing Cash Flow | SGD-183.70MM | SGD-85.52MM | SGD-76.20MM |
| Earnings Per Share** | SGD0.08 | SGD0.05 | SGD0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.